{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:24:25Z","timestamp":1759710265006,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.mehy.2019.109444","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T02:06:59Z","timestamp":1571710019000},"page":"109444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["News and views in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): The role of co-morbidity and novel treatments"],"prefix":"10.1016","volume":"134","author":[{"given":"F.","family":"Comhaire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Deslypere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mehy.2019.109444_b0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/diagnostics9030091","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review","volume":"9","author":"Mastronardi","year":"2019","journal-title":"Diagnostics"},{"key":"10.1016\/j.mehy.2019.109444_b0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/reveh-2015-0026","article-title":"Review of myalgic encephalomyelitis\/chronic fatigue syndrome: an evidence-based approach to diagnosis and management by clinicians","volume":"30","author":"Bested","year":"2015","journal-title":"Rev Environ Health"},{"issue":"3","key":"10.1016\/j.mehy.2019.109444_b0015","doi-asserted-by":"crossref","first-page":"piiE80","DOI":"10.3390\/diagnostics9030080","article-title":"Pathological mechanisms underlying myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"9","author":"Missailidis","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.mehy.2019.109444_b0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mehy.2018.03.002","article-title":"Treating patients suffering from myalgic encephalopathy\/chronic fatigue syndrome (ME\/CFS) with sodium dichloroacetate: an open-label, proof\u2013of-principle pilot trial","volume":"114","author":"Comhaire","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109444_b0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mehy.2018.08.014","article-title":"Why do some ME\/CFS patients benefit from treatment with sodium dichloroacetate, but others do not?","volume":"120","author":"Comhaire","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109444_b0030","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1248\/bpb.b19-00009","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome induced by repeated forced swimming in mice","volume":"42","author":"Ohba","year":"2019","journal-title":"BiolPharm Bull"},{"issue":"6","key":"10.1016\/j.mehy.2019.109444_b0035","article-title":"Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"9","author":"Schlauch","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.mehy.2019.109444_b0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fped.2019.00206","article-title":"Genetic preposition for immune system, hormone, and metabolic dysfunction in myalgic encephalomyelitis\/chronic fatigue syndrome: a pilot study","volume":"7","author":"Perez","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.mehy.2019.109444_b0045","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/15592294.2018.1549769","article-title":"Genome-epigenome interactions with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Herrera","year":"2018","journal-title":"Epigenetics"},{"key":"10.1016\/j.mehy.2019.109444_b0050","doi-asserted-by":"crossref","unstructured":"Comhaire F, Devriendt G. Chronic fatigue syndrome (CFS) or \u201csystemic immune disorder\u201d (SID)? Internal Medicine: open access 2016; 6:5. doi: 10.4172\/2165-8048.1000225.","DOI":"10.4172\/2165-8048.1000225"},{"key":"10.1016\/j.mehy.2019.109444_b0055","first-page":"E5472","article-title":"Metabolic features of chronic fatigue syndrome","volume":"113","author":"Naviaux","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.mehy.2019.109444_b0060","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mehy.2019.109444_b0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C-peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.mehy.2019.109444_b0070","first-page":"154","article-title":"Recent and future evolutions in NeuroSPECT with particular emphasis on the synergistic use of fusion of imaging modalities","volume":"97","author":"D\u2019Asseler","year":"1997","journal-title":"Acta Neurol Belg"},{"issue":"783","key":"10.1016\/j.mehy.2019.109444_b0075","article-title":"Functional connectivity schanges in adults with developmental stuttering: a preliminary study using quantitative electro-encephalography","volume":"8","author":"Joos","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.mehy.2019.109444_b0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0169-2607(95)01703-8","article-title":"MedCalc: a new computer program for medical statistics","volume":"48","author":"Schoonjans","year":"1995","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.mehy.2019.109444_b0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1527-3458.2005.tb00267.x","article-title":"Mildronate: an antiischemic drug for neurological indications","volume":"11","author":"Sjakste","year":"2005","journal-title":"CNS Drug Rev"},{"issue":"PtB","key":"10.1016\/j.mehy.2019.109444_b0090","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.phrs.2016.01.019","article-title":"Pharmacological effects of meldonium: biochemical mechanisms and biomarkers of cardiometabolic activity","volume":"113","author":"Dambrova","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.mehy.2019.109444_b0095","first-page":"47","article-title":"Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome","volume":"2","author":"Lerner","year":"2010","journal-title":"Virus Adapt Treat"},{"key":"10.1016\/j.mehy.2019.109444_b0100","first-page":"25","article-title":"The role of antiviral therapy in chronic fatigue treatment","author":"Henderson","year":"2015","journal-title":"Psychiat Adv"},{"key":"10.1016\/j.mehy.2019.109444_b0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.mehy.2015.10.011","article-title":"Myalgic encephalomyelitis, chronic fatigue syndrome: an infectious disease","volume":"85","author":"Underhill","year":"2015","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109444_b0110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12967-018-1644-y","article-title":"Chronic viral infections in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CVS)","volume":"16","author":"Rasa","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.mehy.2019.109444_b0115","unstructured":"NICE, National, Institute for Health and Care Excellence. Nice guidance, chronic fatigue syndrome Do Not Recommendation. Accessed august, 2019."},{"key":"10.1016\/j.mehy.2019.109444_b0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7326\/M15-0114","article-title":"Treatment of myalgic encephalomyelitis\/chronic fatigue syndrome: a systematic review for a national institutes of health pathway to prevention workshop","volume":"162","author":"Smith","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.mehy.2019.109444_b0125","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3389\/fimmu.2018.01028","article-title":"Association of T and NK cell phenotype with the diagnosis of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"9","author":"Rivas","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2019.109444_b0130","first-page":"348","article-title":"Low NK cell activity in chronic fatigue syndrome (CFS) and relationship to symptom severity","volume":"6","author":"Strayer","year":"2015","journal-title":"J Clin Cell Immunol"},{"issue":"1 Supplement","key":"10.1016\/j.mehy.2019.109444_b0135","first-page":"126","article-title":"Mitochondrial alterations in NK lymphocytes from ME\/CFS patients","volume":"202","author":"Silvestre","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2019.109444_b0140","doi-asserted-by":"crossref","DOI":"10.7326\/M18-1451","article-title":"B-lymphocyte depletion in patients with myalgic encephalomyelitis\/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial","author":"Fluge","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2019.109444_b0145","article-title":"Neurocognition in post-treatment Lyme disease and major depressive disorder","author":"Keilp","year":"2018","journal-title":"Arch Clin Neurophysiol"},{"key":"10.1016\/j.mehy.2019.109444_b0150","unstructured":"Post-Treatment Lyme Disease Syndrome | Lyme Disease (PTLDS).25 jun. 2019| CDC; https:\/\/www.cdc.gov\/lyme\/postlds\/index.html."},{"key":"10.1016\/j.mehy.2019.109444_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2017.10.024","article-title":"Autoimmunity against a glycolytic enzyme as a possible cause of persistent symptoms in Lyme disease","volume":"110","author":"Maccallini","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109444_b0160","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/papt.12118","article-title":"Anxiety and depression in chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME): examining the incidence of health anxiety in ME\/CFS","volume":"90","author":"Daniels","year":"2017","journal-title":"Psychol Psychother"},{"key":"10.1016\/j.mehy.2019.109444_b0165","first-page":"125","article-title":"Dimensional personality assessment among a chronic fatigue syndrome (CFS) sample with personality inventory for DSM)5 (PID-5)","volume":"46","author":"Calvo","year":"2018","journal-title":"Acta Esp Psiquiatr"},{"key":"10.1016\/j.mehy.2019.109444_b0170","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2018.7028","article-title":"Association of stress-related disorders with subsequent autoimmune disease","volume":"319","author":"Song","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2019.109444_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216079","article-title":"Is insulin resistance the cause of fibromyalgia? A preliminary report","author":"Papolla","year":"2019","journal-title":"PlosOne"},{"issue":"3","key":"10.1016\/j.mehy.2019.109444_b0180","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180242","article-title":"Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME\/CFS","volume":"38","author":"Brown","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.mehy.2019.109444_b0185","first-page":"1000177","article-title":"Treating hyperinsulinemia with Momordica charantia","volume":"4","author":"Comhaire","year":"2015","journal-title":"J Metabol Syndr"},{"key":"10.1016\/j.mehy.2019.109444_b0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1940-6207.CAPR-17-0046","article-title":"Bitter melon extract enhances natural killer-mediated toxicity against head and neck cancer cells","volume":"10","author":"BHattcharya","year":"2017","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.mehy.2019.109444_b0195","first-page":"61","article-title":"Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy","volume":"86","author":"Pognikom","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.mehy.2019.109444_b0200","first-page":"470","article-title":"Coenzyme Q10 deficiency in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME\/CFS due to cardiovascular disorder","volume":"30","author":"Maes","year":"2009","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.mehy.2019.109444_b0205","doi-asserted-by":"crossref","first-page":"34990","DOI":"10.1038\/srep34990","article-title":"Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles","volume":"6","author":"Yamano","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2019.109444_b0210","unstructured":"Comhaire F. The internist\u2019s view on myalgic encephalopathy and complementary\/alternative treatments. In: Chronic Fatigue Syndrome. Risk factors, management and impact on daily life. Edit: Connor Hudson. Publ. Neuroscience Research Progress. Nova Scientific Publishers Inc. NY 2014."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719309831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719309831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:19:44Z","timestamp":1759691984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719309831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":42,"alternative-id":["S0306987719309831"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109444","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"News and views in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): The role of co-morbidity and novel treatments","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109444"}}